Minghui Pharmaceutical (hangzhou) Ltd

This study tests an ointment called MH004 in 156 people aged 12 to 65 with non-segmental vitiligo, a condition causing white patches on the skin. The goal is to see if it safely helps restore color, especially on the face, over 24 weeks. Participants apply the ointment and are mo…

This study tests a new drug called MHB036C in 200 adults with advanced solid tumors that have not responded to other treatments. The goal is to find a safe dose and see if the drug can shrink tumors. Participants will receive the drug and be monitored for side effects and how the…

This study tests a new drug called MHB039A in about 196 adults with advanced solid tumors that have not responded to standard treatments. The main goals are to check safety and find the right dose. Researchers will also look at how the drug moves through the body and whether it h…